Amneal Pharmaceuticals (AMRX) Equity Ratio (2017 - 2026)

Amneal Pharmaceuticals' Equity Ratio history runs 10 years deep, the most recent figure standing at 0.01 for Q1 2026.

• In Q1 2026, Equity Ratio rose 67.3% year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (up 67.3% YoY), while the FY2025 annual figure was 0.02, up 38.46% from the prior year.
• Equity Ratio was 0.01 for Q1 2026 at Amneal Pharmaceuticals, up from 0.02 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.1 in Q1 2022 to a low of 0.04 in Q1 2025.
• Historically, Equity Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2026.
• The sharpest annual moves came in 2024 and 2026: Equity Ratio tumbled 642.75% in 2024, then jumped 67.3% in 2026.
• A 5-year view of Equity Ratio shows it stood at 0.05 in 2022, then tumbled by 88.1% to 0.01 in 2023, then sank by 642.75% to 0.03 in 2024, then surged by 38.46% to 0.02 in 2025, then surged by 33.35% to 0.01 in 2026.
• The last three Equity Ratio figures came in at 0.01 (Q1 2026), 0.02 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.